Related Experiment Video
Updated: Apr 28, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Case Report: Atypical anti-KLHL11 antibody encephalitis: recurrent staring spells, serial negative MRI findings, and
Yingyu Xie1, Junling Chen1, Weifan Xu2
1Department of Neurology, Shantou Central Hospital, Shantou Clinical Medical College of Jinan University, Shantou, China.
Abstract:
Anti-Kelch-like protein 11 (KLHL11) antibody encephalitis is a rare autoimmune neurological disorder, typically characterized by cerebellar syndrome and brainstem involvement, with magnetic resonance imaging (MRI) lesions predominantly localized to the brainstem and cerebellum consistent with rhombencephalitis. Epilepsy as the primary clinical presentation of this disease has been rarely reported. Herein, we describe a case of anti-KLHL11 encephalitis in which the patient presented with recurrent staring spells as the chief complaint, accompanied by transient mild cerebella signs. Brain imaging and routine cerebrospinal fluid (CSF) tests were unremarkable during the first two admissions; only generalized slow waves were detected on electroencephalogram (EEG) in the second admission. At the third admission, brain MRI revealed T2 hyperintensities in the left frontal and parietal lobes and CSF examination showed elevated protein levels; subsequent antibody testing confirmed anti-KLHL11-IgG positivity, thereby establishing a definitive diagnosis. The patient had negative results on tumor screening and exhibited a favorable response to therapy with corticosteroids, intravenous immunoglobulin and efgartigimod. This case highlights the diverse clinical manifestations and staged progression of anti-KLHL11 encephalitis, which warrants full recognition in clinical practice. For patients suspected of autoimmune encephalitis, dynamic re-examination of cranial imaging and CSF, as well as timely KLHL11-IgG testing, are critical for early diagnosis and prompt treatment, thereby improving prognosis. Additionally, this case expands the current understanding of anti-KLHL11 antibody encephalitis regarding its clinical presentations, imaging features, and therapeutic responsiveness.
More Related Videos
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Arboviral Encephalitis